Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2021-03-04
TPTXTurning Point Therapeutics, Inc.Reich SiegfriedEVP, Chief Scientific OfficerS - Sale+OE$105.04-35,5503,845-90%-$3,734,075
2021-03-04
RVNCRevance Therapeutics, Inc.Rankin AubreyPres, Innovation, TechS - Sale$25.43-33,119665,405-5%-$842,216
M
2021-03-03
SDGRSchrodinger, Inc.Shaw David E10%S - Sale$83.44-100,0008,762,154-1%-$8,343,827
M
2021-03-03
KROSKeros Therapeutics, Inc.Knowles JuliusDirS - Sale$56.45-23,959420,825-5%-$1,352,499
M
2021-03-03
ALLKAllakos Inc.More Robert Jmember - potential 10% groupS - Sale$114.22-32,5542,071,147-2%-$3,718,319
M
2021-03-03
IRWDIronwood Pharmaceuticals IncDenner Alexander JDir, 10%P - Purchase$10.01+775,00016,202,844+5%+$7,758,750
2021-03-03
ABTAbbott LaboratoriesWainer Andrea FEVPS - Sale$121.79-6,20051,550-11%-$755,098
2021-03-03
RPRXRoyalty Pharma PlcCoyne Terrance P.EVP, CFOS - Sale$44.78-100,000250,390-29%-$4,478,450
2021-03-04
BPMCBlueprint Medicines CorpDurso-Bumpus DebraChief People OfficerS - Sale$86.76-1,69330,874-5%-$146,887
M
2021-03-03
BPMCBlueprint Medicines CorpHurley ArielPrincipal Accounting OfficerS - Sale$91.16-1,37211,799-10%-$125,066
2021-03-04
BPMCBlueprint Medicines CorpHaviland KateCOOS - Sale$86.77-1,95253,948-3%-$169,370
2021-03-04
BPMCBlueprint Medicines CorpLandsittel MichaelCFOS - Sale$86.76-1,50728,905-5%-$130,749
2021-03-04
BPMCBlueprint Medicines CorpMcCain Tracey LEVP, GCS - Sale$86.76-1,89332,852-5%-$164,242
2021-03-04
BPMCBlueprint Medicines CorpMurray Christopher K.SVP, Technical OperationsS - Sale$86.76-1,21018,888-6%-$104,984
2021-03-04
BPMCBlueprint Medicines CorpRossi ChristinaChief Commercial OfficerS - Sale$86.77-1,35931,723-4%-$117,920
D
2021-03-04
BPMCBlueprint Medicines CorpAlbers Jeffrey W.CEO, PresS - Sale+OE$89.28-18,986172,448-10%-$1,695,006
D
2021-03-04
CLRBCellectar Biosciences, Inc.Caruso James VPres, CEOP - Purchase$1.70+5,10086,401+6%+$8,659
D
2021-03-03
SDGRSchrodinger, Inc.D'Cruz ConyEVP, Chief Business OfficerS - Sale+OE$106.90-4,800151,082-3%-$513,120
D
2021-03-03
GBIOGeneration Bio Co.Zimmermann TracyCHIEF DEVELOPMENT OFFICERS - Sale+OE$41.38-3,0000-100%-$124,140
2021-02-23
MACKMerrimack Pharmaceuticals IncCrocker Gary LSee RemarksP - Purchase$7.20+5,00015,104+49%+$36,005
D
2021-03-05
ARQTArcutis Biotherapeutics, Inc.Watanabe Todd FranklinPres, CEOS - Sale+OE$30.55-1,750807,8030%-$53,463
M
2021-03-03
SNSESensei Biotherapeutics, Inc.Cambrian Biopharma Inc10%P - Purchase$15.16+5,0004,776,7940%+$75,800
M
2021-03-03
SNSESensei Biotherapeutics, Inc.Peyer JamesDir, 10%P - Purchase$15.16+5,0004,776,7940%+$75,800
2021-03-04
PHIOPhio Pharmaceuticals Corp.Dispersyn GerritPres, CEOP - Purchase$2.56+1,95389,281+2%+$5,000
ADM
2021-03-01
ALBOAlbireo Pharma, Inc.Mattsson JanChief Scientific OfficerS - Sale+OE$36.85-31,47037,574-46%-$1,159,684
2021-03-02
RPRXRoyalty Pharma PlcLloyd George W.EVP, Investments, GCS - Sale$46.94-125,000651,960-16%-$5,867,148
2021-03-02
RPRXRoyalty Pharma PlcReddoch James F.EVP, Research, InvestmentsS - Sale$46.92-100,000325,030-24%-$4,692,158
2021-03-02
RPRXRoyalty Pharma PlcCoyne Terrance P.EVP, CFOS - Sale$46.94-100,000350,390-22%-$4,694,090
2021-03-03
NLTXNeoleukin Therapeutics, Inc.Walkey CarlSVPS - Sale$11.87-1,8001,373,3620%-$21,360
2021-02-22
EPIXEssa Pharma Inc.Berger Franklin MDirP - Purchase$27.00+57,000957,244+6%+$1,539,000
D
2021-03-03
VTRSViatris IncCornwell W DonDirP - Purchase$13.84+3,0003,000New+$41,515
D
2021-03-02
ITCIIntra-Cellular Therapies, Inc.Marcus Joel SDirS - Sale+OE$34.93-15,2501,263,425-1%-$532,683
2021-03-02
MRTXMirati Therapeutics, Inc.Cherrington Julie MDirS - Sale$201.01-2,0001,475-58%-$402,020
D
2021-03-02
GTHXG1 Therapeutics, Inc.Malik RajeshChief Medical OfficerS - Sale+OE$22.95-15,00043,300-26%-$344,192
DM
2020-12-28
STOKStoke Therapeutics, Inc.Liau GeneEVP Research, Preclinical DevS - Sale+OE$62.93-5,34421,351-20%-$336,297
2021-03-02
PBYIPuma Biotechnology, Inc.Nougues Maximo FCFOS - Sale$10.14-15468,6770%-$1,561
2021-03-02
PBYIPuma Biotechnology, Inc.Hunt Douglas MSee RemarksS - Sale$10.16-42269,218-1%-$4,288
2021-03-02
PBYIPuma Biotechnology, Inc.Bryce Richard PaulSEE REMARKSS - Sale$10.15-422122,0880%-$4,283
2021-03-02
PBYIPuma Biotechnology, Inc.Auerbach Alan HPres, CEO, 10%S - Sale$10.14-1,2384,431,7490%-$12,556
D
2021-03-03
ATNXAthenex, Inc.Wu JinnDirS - Sale+OE$4.75-98,000303,208-24%-$465,500
2021-03-01
GALTGalectin Therapeutics Inc10X Fund, L.P.10%S - Sale$2.31-10,0006,326,4400%-$23,100
DM
2021-03-02
TEVATeva Pharmaceutical Industries LtdO'Grady Brendan P.EVP, North America CommercialS - Sale+OE$10.85-15,54815,571-50%-$168,631
D
2021-03-03
TEVATeva Pharmaceutical Industries LtdNazzi GianfrancoEVP, International MarketsS - Sale+OE$10.88-1,4000-100%-$15,231
2021-03-02
TEVATeva Pharmaceutical Industries LtdFridriksdottir HafrunEVP, Global R, DS - Sale$10.82-50,00064,064-44%-$540,890
D
2021-03-03
TEVATeva Pharmaceutical Industries LtdDethlefs SvenEVP Global Marketing, PortfoliS - Sale+OE$10.86-60670,058-1%-$6,583
D
2021-03-03
TEVATeva Pharmaceutical Industries LtdDaniell RichardEVP, European CommercialS - Sale+OE$10.88-99311,873-8%-$10,803
2021-03-02
QUREUniqure N.V.Kaye JackDirS - Sale$37.60-50418,069-3%-$18,950
2021-03-02
QUREUniqure N.V.Astley-Sparke PhilipDirS - Sale$37.60-5049,946-5%-$18,950
2021-03-02
QUREUniqure N.V.Gut RobertDirS - Sale$36.98-1,30042,001-3%-$48,074
2021-03-02
QUREUniqure N.V.Soteropoulos PaulaDirS - Sale$37.60-5046,364-7%-$18,950
2021-03-02
QUREUniqure N.V.Balachandran MadhavanDirS - Sale$37.50-5059,945-5%-$18,938
2021-03-02
QUREUniqure N.V.Meek David D.DirS - Sale$37.50-5056,448-7%-$18,938
2021-03-02
QUREUniqure N.V.Springhorn Jeremy P.DirS - Sale$37.50-5059,945-5%-$18,938
2021-03-02
QUREUniqure N.V.Kuta Alexander Edward IIIEVP, OperationsS - Sale$37.00-1,20668,871-2%-$44,622
2021-03-02
QUREUniqure N.V.Klemt ChristianChief Accounting OfficerS - Sale$37.03-1,35063,604-2%-$49,991
2021-03-02
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$36.94-4,974273,777-2%-$183,740
2021-03-03
ALLKAllakos Inc.Tomasi AdamPres, COO, CFOS - Sale$113.56-3,189160,268-2%-$362,143
DM
2021-03-03
ALLKAllakos Inc.Rasmussen Henrik S MdChief Medical OfficerS - Sale+OE$116.86-61,952125,087-33%-$7,239,844
D
2021-03-02
IGMSIgm Biosciences, Inc.Keyt BruceChief Scientific OfficerS - Sale+OE$90.25-1,6193,782-30%-$146,115
D
2021-03-02
IGMSIgm Biosciences, Inc.Chen Daniel ShinyuChief Medical OfficerS - Sale+OE$90.25-1,224116,518-1%-$110,466
2021-03-02
BHVNBiohaven Pharmaceutical Holding Co Ltd.Childs John WDirP - Purchase$85.14+10,0002,542,6440%+$851,370
2021-03-03
PHIOPhio Pharmaceuticals Corp.Ferrara Robert LDirP - Purchase$3.15+68213,000+6%+$2,148
2021-03-03
PHIOPhio Pharmaceuticals Corp.Dispersyn GerritPres, CEOP - Purchase$3.03+2,50087,328+3%+$7,575
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Kassberg Thomas RichardCBO, EVPS - Sale+OE$138.17-4,572107,181-4%-$631,713
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Pinion John RichardSee RemarksS - Sale+OE$138.17-6,19850,237-11%-$856,378
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Parschauer Karah HerdmanEVP, GCS - Sale+OE$138.17-3,97030,227-12%-$548,535
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Huizenga Theodore AlanSVP, Controller, PAOS - Sale+OE$138.17-73216,544-4%-$101,140
DM
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Harris ErikEVP, Chief Commercial OfficerS - Sale+OE$138.17-3,17727,813-10%-$438,959
M
2021-03-01
KROSKeros Therapeutics, Inc.Knowles JuliusDirS - Sale$61.13-23,690430,283-5%-$1,448,078
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Huang Dennis KarlEVP, Chief Tech Ops OfficerS - Sale+OE$138.18-4,25540,761-9%-$587,956
D
2021-03-01
CCXIChemocentryx, Inc.Cappel Markus J.Chief Bus. Officer, TreasurerS - Sale+OE$68.43-33,09285,826-28%-$2,264,443
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Bedrosian Camille LEVP, Chief Medical OfficerS - Sale+OE$138.18-4,54339,139-10%-$627,752
D
2021-03-01
RAREUltragenyx Pharmaceutical Inc.Kakkis Emil DPres, CEOS - Sale+OE$141.80-30,0002,885,793-1%-$4,254,000
2021-03-02
CCXIChemocentryx, Inc.Edwards Thomas A.DirS - Sale$70.06-1,100119,857-1%-$77,063
M
2021-03-01
PHATPhathom Pharmaceuticals, Inc.Nabulsi AzmiCOOS - Sale$45.88-14,500795,533-2%-$665,290
2021-03-03
OTICOtonomy, Inc.Lichter JayDirS - Sale$2.70-321,1800-100%-$866,544
2021-03-01
VRNAVerona Pharma PlcHahn Mark WCFOS - Sale$1.14-26,72819,054,5040%-$30,571
2021-03-01
VRNAVerona Pharma PlcZaccardelli DavidPres, CEOS - Sale$1.14-43,39220,050,8480%-$49,627
D
2021-03-01
COLLCollegium Pharmaceutical, IncCiaffoni JosephPres, CEOS - Sale+OE$22.67-64,768278,307-19%-$1,468,425
DM
2018-01-12
COLLCollegium Pharmaceutical, IncFleming Alison BChief Technical OfficerS - Sale+OE$22.60-18,235148,753-11%-$412,169
2021-03-03
XNCRXencor IncEckert CeliaVP, GCS - Sale$44.94-4443,496-11%-$19,955
2021-03-03
XNCRXencor IncDesjarlais John RSVP, CSOS - Sale$45.03-1,16591,788-1%-$52,454
2021-03-03
XNCRXencor IncDahiyat Bassil IPres, CEOS - Sale$44.88-2,850141,064-2%-$127,909
DM
2021-03-01
XNCRXencor IncKuch John JSVP, CFOS - Sale+OE$48.71-15,87085,415-16%-$772,966
2021-03-02
CLSDClearside Biomedical, Inc.Lasezkay George MCEOS - Sale$3.37-6,000433,609-1%-$20,220
2021-03-01
FOLDAmicus Therapeutics, Inc.Crowley John FCOB, CEOS - Sale$11.85-7,500901,601-1%-$88,881
D
2021-03-01
FOLDAmicus Therapeutics, Inc.Campbell Bradley LCOOS - Sale+OE$11.84-10,514378,857-3%-$124,516
2021-03-01
FOLDAmicus Therapeutics, Inc.Whitman Burke WDirP - Purchase$12.40+1,50042,967+4%+$18,600
D
2021-03-01
CLVSClovis Oncology, Inc.Muehl Daniel WSee RemarksS - Sale+OE$6.29-45647,566-1%-$2,868
DM
2021-03-01
ALBOAlbireo Pharma, Inc.Mattsson JanChief Scientific OfficerS - Sale+OE$36.85-31,47037,574-46%-$1,159,684
M
2021-03-01
VNDAVanda Pharmaceuticals Inc.Williams TimothySVP, GCS - Sale$18.58-19,53092,526-17%-$362,850
D
2021-03-02
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale+OE$6.29-580245,0790%-$3,648
2021-03-02
VNDAVanda Pharmaceuticals Inc.Wijkstrom JoakimSVP, CMOS - Sale$18.45-3,88878,202-5%-$71,729
M
2021-03-01
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPres, CEOS - Sale$18.38-22,6851,396,062-2%-$416,905
D
2021-03-02
CLVSClovis Oncology, Inc.Harding Thomas C.See RemarksS - Sale+OE$6.29-30710,477-3%-$1,931
M
2021-03-01
VNDAVanda Pharmaceuticals Inc.Moran Kevin PatrickSVP, CFO, TreasurerS - Sale$18.35-9,371102,061-8%-$171,971
D
2021-03-02
CLVSClovis Oncology, Inc.Gross Paul EdwardSee RemarksS - Sale+OE$6.29-45643,521-1%-$2,868
2021-03-02
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerS - Sale$18.04-3,86596,935-4%-$69,717
M
2021-03-01
VNDAVanda Pharmaceuticals Inc.Birznieks GuntherSVP, Business DevelopmentS - Sale$18.28-20,465171,708-11%-$374,017
D
2021-03-02
CLVSClovis Oncology, Inc.Rolfe LindseySee RemarksS - Sale+OE$6.29-66169,364-1%-$4,158

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top